Skip to main content

Ikarian Capital, LLC

Position in MRNA — Moderna, Inc.

CIK 1778253 DALLAS, TX

Position in MRNA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
8 quarters on record

Common Shares in MRNA Over Time

Shares Held

Position Value (USD)

Derivatives in MRNA

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$28,012,000
PutShares
400,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in MRNA

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $28,012,000 400,000
2024-12-31 $4,158,000 100,000
2023-12-31 $4,405,635 44,300
2023-12-31 $2,441,099 24,546
2023-09-30 $252,337 2,443
2021-03-31 $78,570,000 600,000
2021-03-31 $13,095,000 100,000
2020-12-31 $151,481,500 1,450,000
2020-12-31 $6,483,303 62,059
2020-09-30 $77,393,425 1,093,900
2020-06-30 $1,926,300 30,000
2020-06-30 $19,263,000 300,000